0001104659-21-046726.txt : 20210405
0001104659-21-046726.hdr.sgml : 20210405
20210405201624
ACCESSION NUMBER: 0001104659-21-046726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rhodes Jason P
CENTRAL INDEX KEY: 0001577014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 21807694
MAIL ADDRESS:
STREET 1: C/O EPIZYME, INC.
STREET 2: 400 TECHNOLOGY SQUARE, 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
tm2112099-8_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-01
0
0001737953
Replimune Group, Inc.
REPL
0001577014
Rhodes Jason P
C/O REPLIMUNE GROUP, INC.
500 UNICORN PARK
WOBURN
MA
01801
1
0
0
0
Stock Option (right to buy)
31.58
2021-04-01
4
A
0
16500
0
A
2031-04-01
Common Stock
16500
16500
D
This option was granted on April 1, 2021 with respect to 16,500 shares of the Issuer's common stock and vests in full on April 1, 2022.
The Reporting Person is a member of Atlas Venture Associates X, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
/s/ Jean Franchi, attorney-in-fact
2021-04-05